STOCK TITAN

Green Rain (GREH) questions $20M Medican note and blocks conversions

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Green Rain Energy Holdings is reevaluating a legacy 2019 acquisition of Medican Enterprises Inc. that was financed with a $20,000,000 convertible promissory note bearing 8% annual interest. Current management, which was not involved in the original deal, is reviewing valuation methods, asset ownership, and the accounting treatment of the note.

The company has told its transfer agent and other parties that it regards the Medican note as a purported instrument, not a confirmed binding obligation under its internal records, and has directed them to block any conversions unless expressly authorized in writing by the CEO and Board. The Board has authorized a fair value and impairment review, including possible accounting adjustments and independent expert input, and has requested supporting documentation from counterparties by March 13, 2026.

Positive

  • None.

Negative

  • None.

Insights

Green Rain flags a $20M legacy note for intensive review.

Green Rain Energy Holdings is reexamining a legacy Medican Enterprises acquisition funded by a $20,000,000 convertible note at 8% interest. Current leadership states the note is only a purported obligation in its records and has instructed intermediaries to block conversions without written approval from the CEO and Board.

The Board has launched a broad fair value and impairment review of the acquired intellectual property, equity stakes, and real estate, along with the related liabilities. Resolutions authorize use of independent valuation, accounting, and legal specialists and contemplate possible changes to carrying values and presentation under U.S. GAAP if warranted.

Management is also seeking extensive supporting documentation and valuation support from Medican-related parties, with a response requested by March 13, 2026. Future financial statements may reflect adjustments depending on audit findings and the results of ownership, valuation, and enforceability verification for the Medican assets and the convertible note.

false 0001084937 0001084937 2026-03-04 2026-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 4, 2026

 

 

 

Green Rain Energy Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Wyoming 000-28379 88-0395372
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

 

8549 Wilshire Blvd. Suite 1216  
Beverly Hills, California 90211
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (310) 228-8897

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

   

 

 

Item 8.01 Other Events.

 

On March 4, 2026, Green Rain Energy Holdings, Inc. (the “Company”) advised certain parties, including the Company’s transfer agent, regarding its position with respect to a purported convertible promissory note referred to as the “Medican Note” associated with Medican Enterprises Inc. or related parties. Supporting documents were provided with the communication, outlining the Company’s intent to classify the referenced note as purported and not a binding obligation

 

The communication states that it is the Company’s position the Medican Note is purported and not officially documented or recognized as a valid obligation by the Company based on its internal records. The communication directs such parties, , to block any conversion requests and not to allow or process any conversions of the Medican Note unless expressly authorized in writing by the Company’s CEO and the Board of Directors.

 

The Company considers this matter material to its security holders since unauthorized conversions, could potentially affect the Company’s capital structure, result in unintended dilution, or create disputes regarding the Company’s financial obligations.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   PREDECESSOR MANAGEMENT TRANSACTION DISCLOSURE MEDICAN ENTERPRISES INC. ACQUISITION
     
99.2   LEGACY ACQUISITION IMPAIRMENT REVIEW RESOLUTION (MEDICAN ENTERPRISES — 2019 ACQUISITION)
     
99.3   LEGACY PURCHASE & SALE REVIEW — MEDICAN ENTERPRISES INC. (WYOMING LAW COMPLIANT)
     

99.4

 

  LEGACY ACQUISITION VALIDATION RESOLUTION UNANIMOUS WRITTEN RESOLUTION OF THE BOARD OF DIRECTORS GREEN RAIN ENERGY HOLDINGS INC.
     
104   Cover Page Interactive Data File

 

 

 

 

 

 2 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

GREEN RAIN ENERGY HOLDINGS INC.

A Wyoming Corporation

     
     

 

By:/s/ Alfredo Papadakis
    Alfredo Papadakis
    President & Chief Executive Officer
Date: March 4, 2026    

 

 

 

 

 

 

 

 3 

Exhibit 99.1

 

PREDECESSOR MANAGEMENT TRANSACTION DISCLOSURE

MEDICAN ENTERPRISES INC. ACQUISITION

 

 

The Company entered into a Purchase and Sale Agreement dated January 26, 2019, under predecessor management, pursuant to which the Company acquired certain assets associated with Medican Enterprises Inc.

 

Consideration for the transaction included the issuance of a Convertible Promissory Note in the principal amount of $20,000,000 bearing interest at eight percent (8%) per annum. Assets acquired under the agreement included, among other things, intellectual property, website-related assets, minority equity interests in private entities, and certain real property interests.

 

Current management assumed control of the Company in October 22nd, 2024 and was not involved in the negotiation, valuation, or approval of the transaction. In accordance with its fiduciary obligations under applicable Wyoming corporate law and in connection with ongoing audit procedures, management has initiated a comprehensive review of:

 

·valuation methodologies supporting the original transaction;
·assets acquired compared to consideration issued;
·legal ownership and transfer documentation;
·accounting classification and treatment of the Convertible Promissory Note.

 

Pending completion of the validation and impairment review, acquisition-related assets and liabilities continue to be reflected on an interim basis for financial reporting purposes. Carrying values remain subject to adjustment based upon audit findings and management’s ongoing review.

 

 

GREEN RAIN ENERGY HOLDINGS INC.

 

/s/ Alfredo Papadakis

Alfredo Papadakis

CEO

Exhibit 99.2

 

 

LEGACY ACQUISITION IMPAIRMENT REVIEW RESOLUTION

(MEDICAN ENTERPRISES — 2019 ACQUISITION)

 

ADDITIONAL RECITAL

 

WHEREAS, the acquisition of Medican Enterprises Inc. was financed primarily through issuance of a $20,000,000 Convertible Promissory Note bearing interest at eight percent (8%) per annum, and the Board desires to ensure that the carrying values of acquired assets and related liabilities remain supportable, recoverable, and consistent with applicable accounting standards.

 

ADDITIONAL RESOLUTION LANGUAGE

 

NOW, THEREFORE, BE IT RESOLVED THAT management shall undertake a review to assess, among other things, whether:

 

1.The valuations assigned to intellectual property, equity interests, real property, and other acquired assets reasonably support the consideration reflected by the $20,000,000 Convertible Promissory Note;
   
2.Any acquired assets lack sufficient supporting documentation or measurable fair value;
   
3.Impairment charges or valuation adjustments are required pursuant to applicable accounting standards, including but not limited to ASC 350 (Intangibles — Goodwill and Other) and ASC 360 (Property, Plant, and Equipment);
   
4.The acquired assets collectively support the current carrying value relative to the related convertible note obligation;
   
5.Goodwill, intangible assets, or other long-lived assets require impairment testing or write-down;
   
6.The classification and accounting treatment of the Convertible Promissory Note remain appropriate under applicable U.S. GAAP.

 

IN WITNESS WHEREOF, the undersigned directors have executed this Unanimous Written Resolution effective as of the date first written above.

 

GREEN RAIN ENERGY HOLDINGS INC.

 

/s/ Alfredo Papadakis                                   March 4th, 2026

Alfredo Papadakis

Director

Exhibit 99.3

 

DOCUMENT REQUEST LETTER

 

LEGACY PURCHASE & SALE REVIEW — MEDICAN ENTERPRISES INC.

(WYOMING LAW COMPLIANT)

 

GREEN RAIN ENERGY HOLDINGS INC.

 

Date: ___________________

To: Xavier Mitchell
Medican Enterprises Inc.

 

RE: REQUEST FOR SUPPORTING DOCUMENTATION

LEGACY PURCHASE & SALE AGREEMENT REVIEW

(Pursuant to Wyoming Business Corporation Act & Audit Review)

 

Dear Mr. Mitchell,

 

Green Rain Energy Holdings Inc., (the “Company”), a Wyoming corporation, is conducting a comprehensive review of legacy transactions entered into under predecessor management in connection with the Company’s ongoing audit and financial reporting obligations.

 

This review includes the Purchase and Sale Agreement dated January 26, 2019, entered into between:

·Medican Enterprises Inc.;
·Green Rain Energy Holdings Inc., (the “Company”); and
·Eagle Oil Holding Company Inc. (now Green Stream Holdings Inc.).

 

Current management assumed control in October 22nd, 2024 and was not involved in negotiating or approving this transaction.

 

A. Origin of Convertible Note

 

Records indicate that, pursuant to the January 26, 2019 Purchase and Sale Agreement, the Company issued a Convertible Promissory Note in the principal amount of $20,000,000 bearing interest at 8% per annum as consideration for the transfer of assets.

The Company’s records reflect that consideration included ownership or equity interests in the following:

·Ownership of the book “Living The Hemp Life: An Argumentative Story About Marijuana” (ISBN 978-0-692-72998-4; published July 19, 2016);
·Website known as “Cannabud”;
·25% membership interest — Biodynamic Hemp LLC;
·12% non-dilutable equity — RBA Pharma Inc.;
·5% non-dilutable equity — Axilogy Consulting Corporation;
·20% non-dilutable membership — Medmorized LLC;
·20% non-dilutable equity — CBDVITAPETZ Inc.;
·3% non-dilutable equity — VitaCig Latino Inc.;
·25% non-dilutive equity — Vintage Scripts Pharmacy;
·2% non-dilutive equity and 15% dilutive equity — Jamaican Earth Therapeutics Limited;
·60% ownership interest in approximately 60 acres of farmland located at
68811 Co Rd 384, South Haven, Michigan 49090
Parcel No. 80-09-019-017-00;
·10% non-dilutive equity — Green Gold Acquisitions Inc.

 

 

 

 1 

 

 

B. Documentation Requested (Valuation Support)

 

Please provide documentation supporting:

Valuation Methodology

·Income approach (DCF)
·Market comparables
·Asset-based valuation

 

Financial & Legal Support

·Financial statements
·Federal and state tax returns
·Schedule K-1s
·Depreciation schedules
·NOL carryforwards
·IP registrations
·Deeds & land ownership records
·Equity certificates or membership documents
·Proof of ownership transfer
·Asset appraisal reports
·Board approvals or transaction authorizations

 

Convertible Note Documentation

·Executed note and amendments
·Interest accrual schedules
·Conversion terms
·Subsequent conversion documents
·Fair value calculations at issuance

 

C. Wyoming Corporate Law Notice

 

This request is made pursuant to the Board’s fiduciary obligations under the Wyoming Business Corporation Act, including duties to:

·maintain accurate corporate records;
·ensure fair valuation of corporate assets;
·support financial statement integrity.

 

D. Interim Accounting Position

Pending validation, the acquisition and convertible note may continue to be reflected in Company financial statements on an interim basis. Such recognition does not constitute acknowledgment of valuation accuracy or enforceability by current management.

 

Please provide documentation no later than: March 13, 2026

 

 

 

 2 

 

 

 

Sincerely,

GREEN RAIN ENERGY HOLDINGS INC.

 

 

 

 

 

/s/ Alfredo Nicholas Papadakis

Alfredo Nicholas Papadakis

CEO

 

 

 

 

 

 

 

 

 

 3 

 

Exhibit 99.4

 

LEGACY ACQUISITION VALIDATION RESOLUTION

UNANIMOUS WRITTEN RESOLUTION OF THE BOARD OF DIRECTORS

GREEN RAIN ENERGY HOLDINGS INC.

 

 

DATED: March 4th, 2026

 

RECITALS

 

WHEREAS, predecessor management issued a $20,000,000 Convertible Promissory Note bearing interest at eight percent (8%) per annum in connection with the 2019 acquisition of Medican Enterprises Inc.;

 

WHEREAS, current management assumed control of the Company in November 2024 and did not participate in negotiating, valuing, or approving such instrument or the related acquisition;

 

WHEREAS, the Board has determined that supporting valuation documentation and transaction records may be incomplete or unavailable;

 

WHEREAS, the 2019 Purchase and Sale Agreement provided for the issuance of the Convertible Note in exchange for various assets, including intellectual property, equity interests, real property interests, and other assets identified within the transaction documentation;

 

WHEREAS, the Board desires to ensure proper verification of ownership, valuation, and legal enforceability of such assets consistent with its fiduciary obligations under the laws of the State of Wyoming.

 

RESOLUTIONS

 

NOW, THEREFORE, BE IT RESOLVED THAT:

 

1. Authorization of Fair Value Reevaluation

Management is hereby authorized and directed to conduct a fair value reevaluation of the Convertible Promissory Note and related acquisition consideration.

 

2. Engagement of Independent Specialists

Management may retain independent valuation professionals, accountants, legal counsel, or other qualified advisors as deemed necessary to assist with such reevaluation.

 

 

 

 

 1 

 

 

3. Scope of Reevaluation

The reevaluation shall include, without limitation:

·fair value as of the original issuance date (2019);
·fair value as of the management transition period (November 2024);
·current fair value assessment for financial reporting purposes.

 

4. Potential Accounting Adjustments

The Board acknowledges that the reevaluation process may result in adjustments to accounting treatment, carrying values, or financial statement presentation, as required under applicable accounting standards.

 

5. Asset Validation Review

Management is further authorized and directed to validate:

·the existence and ownership of all assets acquired pursuant to the Purchase and Sale Agreement;
·the valuation assigned to each such asset;
·documentation evidencing legal transfer and ownership rights.

 

6. Corporate Records

This resolution shall be inserted into the official minute book of the Company and maintained as part of its permanent corporate records.

 

IN WITNESS WHEREOF, the undersigned directors have executed this Unanimous Written Resolution effective as of the date first written above.

 

 

 

GREEN RAIN ENERGY HOLDINGS INC.

 

 

/s/ Alfredo Papadakis

Alfredo Papadakis

Director

 

 

  

 

 

 2 

 

FAQ

What is Green Rain Energy Holdings (GREH) disclosing about the Medican note?

Green Rain Energy Holdings discloses that a legacy Medican Enterprises acquisition involved a $20,000,000 convertible note at 8% interest. Current management views this Medican note as a purported obligation and has ordered that any conversions be blocked without written approval from the CEO and Board.

Why does Green Rain Energy Holdings (GREH) consider the Medican note issue material?

The company considers the Medican note issue material because unauthorized conversions could change its capital structure, create unintended dilution, or trigger disputes over financial obligations. These potential effects on shares and liabilities directly matter to security holders and overall financial reporting clarity.

What review has Green Rain Energy Holdings (GREH) launched on the 2019 Medican acquisition?

Green Rain has initiated a comprehensive review of the 2019 Medican acquisition, examining valuation methodologies, asset ownership, legal transfer documentation, and U.S. GAAP classification of the $20,000,000 convertible note. This includes potential impairment testing of goodwill, intangibles, and long-lived assets tied to the transaction.

How is Green Rain Energy Holdings (GREH) handling accounting for the Medican acquisition during the review?

During the review, acquisition-related assets and liabilities remain reflected on an interim basis in financial statements. The Board acknowledges that subsequent fair value and impairment analyses may require adjustments to carrying values, classifications, or presentation once audit procedures and validation are complete.

What documentation has Green Rain Energy Holdings (GREH) requested from Medican-related parties?

The company requested extensive documentation, including valuation methodologies, financial statements, tax returns, IP and land records, equity certificates, proof of ownership transfers, executed note documents, and conversion records. It asked that this supporting information be provided by March 13, 2026 to support its audit and corporate law obligations.

What authority has the Green Rain Energy Holdings (GREH) Board given management regarding the Medican note?

The Board authorized management to conduct a fair value reevaluation of the convertible note and related consideration, retain independent valuation, accounting, and legal advisors, and validate ownership and valuation of all acquired assets. It recognizes this process may lead to required accounting and financial statement adjustments.

Filing Exhibits & Attachments

7 documents
Green Rain Energy Holdings Inc

OTC:GREH

GREH Rankings

GREH Latest News

GREH Latest SEC Filings

GREH Stock Data

146.47k
2.52M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Portland